Targeting MET: why, where and how?
Author:
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference52 articles.
1. Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy;Weinstein;Nat Clin Pract Oncol,2006
2. The discovery of receptor tyrosine kinases: targets for cancer therapy;Gschwind;Nat Rev Cancer,2004
3. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy;Sierra;Mol Cancer,2010
4. Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis;Cepero;Curr Pharm Des,2010
5. Molecular cancer therapy: can our expectation be MET?;Migliore;Eur J Cancer,2008
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulation;Cancer Letters;2024-11
2. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31
3. Computer‐Assisted Identification of Inhibitor with Novel Pharmacophore Targeting First Kringle Domain of Hepatocyte Growth Factor;ChemistrySelect;2023-09-21
4. Growth factors and their peptide mimetics for treatment of traumatic brain injury;Bioorganic & Medicinal Chemistry;2023-07
5. Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis;Journal of Clinical Medicine;2022-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3